Document is current

Any future updates will be listed below

Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-020-04504-x

Published Online: 2020-06-16

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark